[1]赵军.充分发挥PET-CT在临床决策中的优势[J].国际放射医学核医学杂志,2012,36(6):321-322.[doi:10.3760/cma.j.issn.1673-4114.2012.06.001]

点击复制

充分发挥PET-CT在临床决策中的优势(/HTML)

分享到：

参考文献/References:

[1] 中华医学会核医学分会.2012年全国核医学现状普查简报.中华核医学杂志,2012,32(5):357,362.
[2] Buck AK,Herrmann K,Stargardt T,et al.Economic evaluation of PET and PET/CT in oncology:evidence and methodologic approaches.J Nucl Med,2010,51(3):401-412.
[3] Delbeke D,Coleman RE,Guiberteau MJ,et al.Procedure guideline for tumor imaging with ¹⁸F-FDG PET/CT 1.0.J Nucl Med,2006,47(5):885-895.
[4] Wahl RL,Jacene H,Kasamon Y,et al.From RECIST to PERCIST:evolving considerations for PET response criteria in solid tumors.J Nucl Med,2009,50 Suppl 1:122S-150.
[5] 黄钢,赵军,刘建军,等.客观评价¹⁸F-FDG PET/CT肿瘤显像误诊现象.中华核医学杂志,2007,27(3):129-130.
[6] Beyer T,Czernin J,Freudenberg LS.Variations in clinical PET/CT operations:results of an international survey of active PET/CT users.J Nucl Med,2011,52(2):303-310.
[7] Karantanis D,Kalkanis D,Allen-Auerbach M,et al.Oncologic ¹⁸F-FDG PET/CT:referring physicians’ point of view.J Nucl Med,2012,53(10):1499-1505.